"EMOR remains quite a mystery to me" I can see
Post# of 30028
(Total Views: 575)
Posted On: 08/04/2020 11:43:32 AM
Re: jamesfranklin #28671
"EMOR remains quite a mystery to me"
I can see why you say that. And yet very competent highly talented people continue to join forces with them.
Now Ian will have a company that has generated $120 mil.
"Carie’s strategic acquisition target currently generates annual revenues greater than $120 million, thereby enhancing the Company’s financial position. Top line revenues as well as the profit margins on these revenues are expected to be enhanced by integration into the Carie ecosystem."
They have MANF, ESS and Phenoguard.
People can continue to say they are "worthless" and easily site because "nobody wants them" , "they are useless" and the proof is "zero money" has been made and they may be right.
They also may not be seeing the big picture.
Also, remember EMOR and TODOS have JV.
Who's to say they don't have PO's on their desk that they can show these companies & physicians why they have incentives to jump aboard.
And then again, they may not have PO's.
But, the what is happening even if the why isn't "directly" being shown to the general public.
I've posted everything that EMOR / Carie has going on.
It's just the question of can people see the big picture and can Ian pull it off.
I think all of this is leading to something big with TODOS and therefore AMBS as well on top of what AMBS has to gain with its direct connection with EMOR / Carie.
It seems we will see this quarter how this just may play out.
Aloha
I can see why you say that. And yet very competent highly talented people continue to join forces with them.
Now Ian will have a company that has generated $120 mil.
"Carie’s strategic acquisition target currently generates annual revenues greater than $120 million, thereby enhancing the Company’s financial position. Top line revenues as well as the profit margins on these revenues are expected to be enhanced by integration into the Carie ecosystem."
They have MANF, ESS and Phenoguard.
People can continue to say they are "worthless" and easily site because "nobody wants them" , "they are useless" and the proof is "zero money" has been made and they may be right.
They also may not be seeing the big picture.
Also, remember EMOR and TODOS have JV.
Who's to say they don't have PO's on their desk that they can show these companies & physicians why they have incentives to jump aboard.
And then again, they may not have PO's.
But, the what is happening even if the why isn't "directly" being shown to the general public.
I've posted everything that EMOR / Carie has going on.
It's just the question of can people see the big picture and can Ian pull it off.
I think all of this is leading to something big with TODOS and therefore AMBS as well on top of what AMBS has to gain with its direct connection with EMOR / Carie.
It seems we will see this quarter how this just may play out.
Aloha
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼